30 Sept 2026, 09:12
Company UpdateMS
VBSVECTUS BIOSYSTEMS LIMITED
Announcement history available from 1 August 2025
Fromto
25 Sept 2026, 15:33
Presentations—
18 Sept 2026, 14:05
Company Administration—
18 Sept 2026, 14:01
Financial Results—
9 Sept 2026, 16:54
Meetings & Governance—
4 Sept 2026, 15:27
Director Interests—
2 Sept 2026, 16:34
Securities Administration—
2 Sept 2026, 16:29
Securities Administration—
31 Aug 2026, 07:50
Financial Results—
31 Aug 2026, 07:50
Financial ResultsMS
29 July 2026, 18:25
Securities Administration—
29 July 2026, 18:21
Securities Administration—
28 July 2026, 17:58
Quarterly ReportsMS
13 July 2026, 09:53
Company Update—
26 June 2026, 16:19
Securities Administration—
26 June 2026, 16:14
Securities Administration—
17 June 2026, 08:17
Presentations—
29 May 2026, 17:17
Substantial Holders—
28 May 2026, 09:57
Substantial Holders—
27 May 2026, 19:15
Securities Administration—
27 May 2026, 11:56
Securities Administration—
22 May 2026, 17:03
Securities Administration—
22 May 2026, 15:18
Capital RaisingMS
15 May 2026, 08:20
Presentations—
12 May 2026, 17:26
Securities Administration—
12 May 2026, 17:21
Securities Administration—
8 May 2026, 15:33
Securities Administration—
8 May 2026, 15:29
Securities Administration—
8 May 2026, 15:25
Securities Administration—
7 May 2026, 17:09
Company AdministrationMS
30 Apr 2026, 15:10
Quarterly ReportsMS
14 Apr 2026, 08:12
Company UpdateMS
26 Feb 2026, 12:25
Financial ResultsMS
30 Jan 2026, 14:49
Quarterly ReportsMS
23 Dec 2025, 12:39
Securities Administration—
23 Dec 2025, 12:35
Securities Administration—
4 Dec 2025, 15:14
Securities Administration—
4 Dec 2025, 15:03
Securities Administration—
26 Nov 2025, 16:25
Meetings & Governance—
26 Nov 2025, 12:04
Presentations—
11 Nov 2025, 15:51
ASX QueryMS
30 Oct 2025, 18:28
Quarterly ReportsMS
24 Oct 2025, 16:14
Meetings & Governance—
17 Oct 2025, 18:37
ReinstatementMS
17 Oct 2025, 18:37
Company UpdateMS
17 Oct 2025, 12:12
Trading Halt / SuspensionMS
15 Oct 2025, 14:44
Trading Halt / SuspensionMS
15 Oct 2025, 13:11
Trading Halt / SuspensionMS
9 Oct 2025, 11:17
Meetings & Governance—
29 Sept 2025, 12:54
Company Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 09:12 | FDA Pre-IND Meeting Request Granted for VB0004 | Company Update | MS | 11001 | |
| 25 Sept 2026, 15:33 | 2026 Notice of Annual General Meeting & Proxy Form | Presentations | — | 08001, 08004, 14014 | |
| 18 Sept 2026, 14:05 | 2026 Corporate Governance Statement & Appendix 4G | Company Administration | — | 03024, 03025 | |
| 18 Sept 2026, 14:01 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 9 Sept 2026, 16:54 | Date of 2026 Annual General Meeting | Meetings & Governance | — | 08006 | |
| 4 Sept 2026, 15:27 | Change of Director's Interest Notice - MS | Director Interests | — | 02009 | |
| 2 Sept 2026, 16:34 | Cleansing Notice | Securities Administration | — | 06018 | |
| 2 Sept 2026, 16:29 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 31 Aug 2026, 07:50 | Full Year Statutory Accounts | Financial Results | — | 03011, 03012, 03013, 03020 | |
| 31 Aug 2026, 07:50 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 29 July 2026, 18:25 | Cleansing Notice | Securities Administration | — | 06018 | |
| 29 July 2026, 18:21 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 28 July 2026, 17:58 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19004, 19009 | |
| 13 July 2026, 09:53 | VBS Engages CHRS as Regulatory Agent for FDA Submissions | Company Update | — | 11001 | |
| 26 June 2026, 16:19 | Cleansing Notice | Securities Administration | — | 06018 | |
| 26 June 2026, 16:14 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 17 June 2026, 08:17 | CEO Investor Webinar | Presentations | — | 12008, 14014 | |
| 29 May 2026, 17:17 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 28 May 2026, 09:57 | Change in substantial holding KHPL | Substantial Holders | — | 02002 | |
| 27 May 2026, 19:15 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 May 2026, 11:56 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 22 May 2026, 17:03 | Proposed issue of securities - VBS | Securities Administration | — | 06013 | |
| 22 May 2026, 15:18 | Placement of Shares | Capital Raising | MS | 06003 | |
| 15 May 2026, 08:20 | Updated Corporate Presentation | Presentations | — | 03026 | |
| 12 May 2026, 17:26 | Cleansing Notice | Securities Administration | — | 06018 | |
| 12 May 2026, 17:21 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 8 May 2026, 15:33 | Cleansing Notice | Securities Administration | — | 06018 | |
| 8 May 2026, 15:29 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 8 May 2026, 15:25 | Notification regarding unquoted securities - VBS | Securities Administration | — | 06021 | |
| 7 May 2026, 17:09 | Appointment of Dr Tara Speranza as CEO & CTO | Company Administration | MS | 12008, 12019 | |
| 30 Apr 2026, 15:10 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19003, 19008 | |
| 14 Apr 2026, 08:12 | VB4-P5 Renal Compound Transaction Settled | Company Update | MS | 11001 | |
| 26 Feb 2026, 12:25 | Half Year Report & Appendix 4D | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 30 Jan 2026, 14:49 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19002, 19007 | |
| 23 Dec 2025, 12:39 | Cleansing Notice | Securities Administration | — | 06018 | |
| 23 Dec 2025, 12:35 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 4 Dec 2025, 15:14 | Cleansing Notice | Securities Administration | — | 06018 | |
| 4 Dec 2025, 15:03 | Application for quotation of securities - VBS | Securities Administration | — | 06020 | |
| 26 Nov 2025, 16:25 | Results of 2025 AGM | Meetings & Governance | — | 08003 | |
| 26 Nov 2025, 12:04 | 2025 AGM Presentations | Presentations | — | 03026, 15002 | |
| 11 Nov 2025, 15:51 | Response to ASX Query Letter | ASX Query | MS | 17003 | |
| 30 Oct 2025, 18:28 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19001, 19006 | |
| 24 Oct 2025, 16:14 | Notice of 2025 Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 17 Oct 2025, 18:37 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 17 Oct 2025, 18:37 | VB4-P5 Renal Compound Transaction | Company Update | MS | 11001 | |
| 17 Oct 2025, 12:12 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 15 Oct 2025, 14:44 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 15 Oct 2025, 13:11 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 9 Oct 2025, 11:17 | Date of 2025 Annual General Meeting | Meetings & Governance | — | 08006 | |
| 29 Sept 2025, 12:54 | 2025 Corporate Governance Statement & Appendix 4G | Company Administration | — | 03024, 03025 |
1–50 of 53
1 / 2